Opus Capital Group, LLC Eli Lilly & CO Transaction History

Opus Capital Group, LLC

  • $685 Million
  • Q1 2024

A detailed history of Opus Capital Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Opus Capital Group, LLC holds 1,120 shares of LLY stock, worth $960,366. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,120
Previous 1,279 12.43%
Holding current value
$960,366
Previous $746,000 16.76%
% of portfolio
0.13%
Previous 0.12%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024
SELL
$592.2 - $792.28 $94,159 - $125,972
-159 Reduced 12.43%
1,120 $871,000
Q4 2023

Jan 31, 2024
SELL
$525.19 - $619.13 $6,302 - $7,429
-12 Reduced 0.93%
1,279 $746,000
Q3 2023

Oct 31, 2023
SELL
$434.7 - $599.3 $54,337 - $74,912
-125 Reduced 8.83%
1,291 $693,000
Q2 2023

Jul 31, 2023
BUY
$350.74 - $468.98 $6,664 - $8,910
19 Added 1.36%
1,416 $664,000
Q1 2023

Apr 24, 2023
SELL
$310.63 - $364.82 $7,455 - $8,755
-24 Reduced 1.69%
1,397 $480,000
Q4 2022

Jan 18, 2023
SELL
$321.55 - $374.67 $17,685 - $20,606
-55 Reduced 3.73%
1,421 $520,000
Q3 2022

Oct 31, 2022
SELL
$296.48 - $337.87 $2,964 - $3,378
-10 Reduced 0.67%
1,476 $477,000
Q2 2022

Jul 29, 2022
SELL
$278.73 - $327.27 $145,218 - $170,507
-521 Reduced 25.96%
1,486 $482,000
Q1 2022

Apr 25, 2022
SELL
$234.69 - $291.66 $704 - $874
-3 Reduced 0.15%
2,007 $575,000
Q4 2021

Jan 31, 2022
BUY
$224.85 - $279.04 $674 - $837
3 Added 0.15%
2,010 $555,000
Q3 2021

Oct 29, 2021
SELL
$221.6 - $272.71 $166,200 - $204,532
-750 Reduced 27.2%
2,007 $464,000
Q2 2021

Jul 29, 2021
SELL
$180.55 - $233.54 $38,457 - $49,744
-213 Reduced 7.17%
2,757 $633,000
Q1 2021

Apr 28, 2021
SELL
$164.32 - $212.72 $93,169 - $120,612
-567 Reduced 16.03%
2,970 $555,000
Q3 2020

Oct 30, 2020
SELL
$146.22 - $169.13 $82,614 - $95,558
-565 Reduced 13.77%
3,537 $524,000
Q2 2020

Jul 31, 2020
SELL
$136.42 - $164.18 $5,456 - $6,567
-40 Reduced 0.97%
4,102 $673,000
Q1 2020

Apr 30, 2020
SELL
$119.05 - $147.35 $40,357 - $49,951
-339 Reduced 7.57%
4,142 $575,000
Q4 2019

Jan 31, 2020
BUY
$106.92 - $132.43 $155,675 - $192,818
1,456 Added 48.13%
4,481 $589,000
Q2 2019

Aug 08, 2019
SELL
$110.79 - $129.32 $228,781 - $267,045
-2,065 Reduced 40.57%
3,025 $335,000
Q4 2018

Feb 07, 2019
BUY
$105.9 - $118.64 $539,031 - $603,877
5,090 New
5,090 $590,000

Others Institutions Holding LLY

# of Institutions
3,747
Shares Held
737M
Call Options Held
7.09M
Put Options Held
7.22M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $815B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Opus Capital Group, LLC Portfolio

Follow Opus Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opus Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email